{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:30:35Z","timestamp":1792074635147,"version":"4.4.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100006668","name":"Fondo para la Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["2021-0509"],"award-info":[{"award-number":["2021-0509"]}],"id":[{"id":"10.13039\/501100006668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006668","name":"Fondo para la Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["2019-03419"],"award-info":[{"award-number":["2019-03419"]}],"id":[{"id":"10.13039\/501100006668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006668","name":"Fondo para la Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["2019-03692"],"award-info":[{"award-number":["2019-03692"]}],"id":[{"id":"10.13039\/501100006668","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s12035-023-03897-5","type":"journal-article","created":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T18:01:58Z","timestamp":1704304918000},"page":"5142-5160","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Loss of Direct Vascular Contact to Astrocytes in the Hippocampus as an Initial Event in Alzheimer\u2019s Disease. Evidence from Patients, In Vivo and In Vitro Experimental Models"],"prefix":"10.1007","volume":"61","author":[{"given":"C.","family":"Pomilio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Presa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Oses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Vinuesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bentivegna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gregosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Riudavets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Sevlever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Galvan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Levi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Beauquis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0781-0140","authenticated-orcid":false,"given":"F.","family":"Saravia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,3]]},"reference":[{"key":"3897_CR1","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.14336\/AD.2022.0412","volume":"13","author":"T Wu","year":"2022","unstructured":"Wu T, Lin D, Cheng Y, Jiang S, Riaz MW, Fu N, Mou C, Ye M et al (2022) Amyloid cascade hypothesis for the treatment of Alzheimer\u2019s disease: progress and challenges. Aging Dis 13:1745\u20131758","journal-title":"Aging Dis"},{"key":"3897_CR2","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA (1992) Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science 256:184\u2013185","journal-title":"Science"},{"key":"3897_CR3","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med 8:595\u2013608","journal-title":"EMBO Mol Med"},{"key":"3897_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41582-019-0281-2","volume":"16","author":"SM Greenberg","year":"2020","unstructured":"Greenberg SM, Bacskai BJ, Hernandez-Guillamon M, Pruzin J, Sperling R, van Veluw SJ (2020) Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways. Nat Rev Neurol 16:30\u201342","journal-title":"Nat Rev Neurol"},{"key":"3897_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1006\/abbi.1993.1112","volume":"301","author":"DL Miller","year":"1993","unstructured":"Miller DL, Papayannopoulos IA, Styles J, Bobin SA, Lin YY, Biemann K, Iqbal K (1993) Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer\u2019s disease. Arch Biochem Biophys 301:41\u201352","journal-title":"Arch Biochem Biophys"},{"key":"3897_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.5853\/jos.2015.17.1.17","volume":"17","author":"M Yamada","year":"2015","unstructured":"Yamada M (2015) Cerebral amyloid angiopathy: emerging concepts. J Stroke 17:17\u201330","journal-title":"J Stroke"},{"key":"3897_CR7","doi-asserted-by":"publisher","first-page":"11934","DOI":"10.1038\/ncomms11934","volume":"7","author":"Y Iturria-Medina","year":"2016","unstructured":"Iturria-Medina Y, Sotero RC, Toussaint PJ, Mateos-Perez JM, Evans AC, and Initiative Alzheimer\u2019s Disease Neuroimaging (2016) Early role of vascular dysregulation on late-onset Alzheimer\u2019s disease based on multifactorial data-driven analysis. Nat Commun 7:11934","journal-title":"Nat Commun"},{"key":"3897_CR8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/jnc.14687","volume":"150","author":"NK Jha","year":"2019","unstructured":"Jha NK, Jha SK, Kar R, Nand P, Swati K, Goswami VK (2019) Nuclear factor-kappa beta as a therapeutic target for Alzheimer\u2019s disease. J Neurochem 150:113\u2013137","journal-title":"J Neurochem"},{"key":"3897_CR9","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng F, Edison P (2021) Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat Rev Neurol 17:157\u2013172","journal-title":"Nat Rev Neurol"},{"key":"3897_CR10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.2174\/1570159X20666220922153903","volume":"21","author":"S Koerich","year":"2023","unstructured":"Koerich S, Parreira GM, de Almeida DL, Vieira RP, de Oliveira ACP (2023) Receptors for advanced glycation end products (RAGE): promising targets aiming at the treatment of neurodegenerative conditions. Curr Neuropharmacol 21:219\u2013234","journal-title":"Curr Neuropharmacol"},{"key":"3897_CR11","doi-asserted-by":"publisher","first-page":"e1299","DOI":"10.1038\/cddis.2014.258","volume":"5","author":"R Park","year":"2014","unstructured":"Park R, Kook SY, Park JC, Mook-Jung I (2014) Abeta1-42 reduces P-glycoprotein in the blood-brain barrier through RAGE-NF-kappaB signaling. Cell Death Dis 5:e1299","journal-title":"Cell Death Dis"},{"key":"3897_CR12","doi-asserted-by":"crossref","unstructured":"Tolstova AP, Adzhubei AA, Mitkevich VA, Petrushanko IY, Makarov AA (2022) \u2018Docking and molecular dynamics-based identification of interaction between various beta-amyloid isoforms and RAGE receptor\u2019. Int J Mol Sci 23","DOI":"10.3390\/ijms231911816"},{"key":"3897_CR13","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.expneurol.2009.12.022","volume":"222","author":"J Beauquis","year":"2010","unstructured":"Beauquis J, Homo-Delarche F, Giroix MH, Ehses J, Coulaud J, Roig P, Portha B, De Nicola AF et al (2010) Hippocampal neurovascular and hypothalamic-pituitary-adrenal axis alterations in spontaneously type 2 diabetic GK rats. Exp Neurol 222:125\u2013134","journal-title":"Exp Neurol"},{"key":"3897_CR14","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/jnc.15166","volume":"156","author":"J Diniz Pereira","year":"2021","unstructured":"Diniz Pereira J, Gomes Fraga V, Morais Santos AL, Carvalho MDG, Caramelli P, Braga Gomes K (2021) Alzheimer\u2019s disease and type 2 diabetes mellitus: a systematic review of proteomic studies. J Neurochem 156:753\u2013776","journal-title":"J Neurochem"},{"key":"3897_CR15","doi-asserted-by":"publisher","first-page":"653651","DOI":"10.3389\/fnins.2021.653651","volume":"15","author":"A Vinuesa","year":"2021","unstructured":"Vinuesa A, Pomilio C, Gregosa A, Bentivegna M, Presa J, Bellotto M, Saravia F, Beauquis J (2021) Inflammation and insulin resistance as risk factors and potential therapeutic targets for Alzheimer\u2019s disease. Front Neurosci 15:653651","journal-title":"Front Neurosci"},{"key":"3897_CR16","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrn3114","volume":"12","author":"BV Zlokovic","year":"2011","unstructured":"Zlokovic BV (2011) Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders. Nat Rev Neurosci 12:723\u2013738","journal-title":"Nat Rev Neurosci"},{"key":"3897_CR17","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/nn.3371","volume":"16","author":"S Bardehle","year":"2013","unstructured":"Bardehle S, Kr\u00fcger M, Buggenthin F, Schwausch J, Ninkovic J, Clevers H, Snippert HJ, Theis FJ et al (2013) Live imaging of astrocyte responses to acute injury reveals selective juxtavascular proliferation. Nat Neurosci 16:580\u2013586","journal-title":"Nat Neurosci"},{"key":"3897_CR18","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1172\/JCI91301","volume":"127","author":"S Horng","year":"2017","unstructured":"Horng S, Therattil A, Moyon S, Gordon A, Kim K, Argaw AT, Hara Y, Mariani JN et al (2017) Astrocytic tight junctions control inflammatory CNS lesion pathogenesis. J Clin Invest 127:3136\u20133151","journal-title":"J Clin Invest"},{"key":"3897_CR19","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1002\/glia.23908","volume":"69","author":"BP Heithoff","year":"2021","unstructured":"Heithoff BP, George KK, Phares AN, Zuidhoek IA, Munoz-Ballester C, Robel S (2021) Astrocytes are necessary for blood-brain barrier maintenance in the adult mouse brain. Glia 69:436\u2013472","journal-title":"Glia"},{"key":"3897_CR20","first-page":"1890","volume":"18","author":"Q Yue","year":"2023","unstructured":"Yue Q, Hoi MPM (2023) Emerging roles of astrocytes in blood-brain barrier disruption upon amyloid-beta insults in Alzheimer\u2019s disease. Neural Regen Res 18:1890\u20131902","journal-title":"Neural Regen Res"},{"key":"3897_CR21","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S1474-4422(18)30490-3","volume":"18","author":"AM Arranz","year":"2019","unstructured":"Arranz AM, De Strooper B (2019) The role of astroglia in Alzheimer\u2019s disease: pathophysiology and clinical implications. Lancet Neurol 18:406\u2013414","journal-title":"Lancet Neurol"},{"key":"3897_CR22","doi-asserted-by":"publisher","first-page":"584135","DOI":"10.3389\/fphys.2020.584135","volume":"11","author":"JL Presa","year":"2020","unstructured":"Presa JL, Saravia F, Bagi Z, Filosa JA (2020) Vasculo-neuronal coupling and neurovascular coupling at the neurovascular unit: impact of hypertension. Front Physiol 11:584135","journal-title":"Front Physiol"},{"key":"3897_CR23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrn1824","volume":"7","author":"NJ Abbott","year":"2006","unstructured":"Abbott NJ, Ronnback L, Hansson E (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7:41\u201353","journal-title":"Nat Rev Neurosci"},{"key":"3897_CR24","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.neuroimage.2015.11.014","volume":"127","author":"C Demene","year":"2016","unstructured":"Demene C, Tiran E, Sieu LA, Bergel A, Gennisson JL, Pernot M, Deffieux T, Cohen I et al (2016) 4D microvascular imaging based on ultrafast Doppler tomography. Neuroimage 127:472\u2013483","journal-title":"Neuroimage"},{"key":"3897_CR25","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1161\/STROKEAHA.122.038263","volume":"54","author":"AC Johnson","year":"2023","unstructured":"Johnson AC (2023) Hippocampal vascular supply and its role in vascular cognitive impairment. Stroke 54:673\u2013685","journal-title":"Stroke"},{"key":"3897_CR26","doi-asserted-by":"crossref","unstructured":"Soto-Rojas LO, Pacheco-Herrero M, Martinez-Gomez PA, Campa-Cordoba BB, Apatiga-Perez R, Villegas-Rojas MM, Harrington CR, de la Cruz F et al (2021) \u2018The neurovascular unit dysfunction in Alzheimer\u2019s disease\u2019. Int J Mol Sci 22","DOI":"10.3390\/ijms22042022"},{"key":"3897_CR27","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/jnc.13122","volume":"134","author":"W Wan","year":"2015","unstructured":"Wan W, Cao L, Liu L, Zhang C, Kalionis B, Tai X, Li Y, Xia S (2015) Abeta(1\u201342) oligomer-induced leakage in an in vitro blood-brain barrier model is associated with up-regulation of RAGE and metalloproteinases, and down-regulation of tight junction scaffold proteins. J Neurochem 134:382\u2013393","journal-title":"J Neurochem"},{"key":"3897_CR28","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s12264-022-00977-9","volume":"39","author":"D Yao","year":"2023","unstructured":"Yao D, Zhang R, Xie M, Ding F, Wang M, Wang W (2023) Updated understanding of the glial-vascular unit in central nervous system disorders. Neurosci Bull 39:503\u2013518","journal-title":"Neurosci Bull"},{"key":"3897_CR29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.trsl.2022.12.003","volume":"254","author":"LB Eisenmenger","year":"2023","unstructured":"Eisenmenger LB, Peret A, Famakin BM, Spahic A, Roberts GS, Bockholt JH, Johnson KM, Paulsen JS (2023) Vascular contributions to Alzheimer\u2019s disease. Transl Res 254:41\u201353","journal-title":"Transl Res"},{"key":"3897_CR30","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1093\/brain\/aws243","volume":"135","author":"A Dorr","year":"2012","unstructured":"Dorr A, Sahota B, Chinta LV, Brown ME, Lai AY, Ma K, Hawkes CA, McLaurin J et al (2012) Amyloid-beta-dependent compromise of microvascular structure and function in a model of Alzheimer\u2019s disease. Brain 135:3039\u20133050","journal-title":"Brain"},{"key":"3897_CR31","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1093\/brain\/awv327","volume":"138","author":"IF Kimbrough","year":"2015","unstructured":"Kimbrough IF, Robel S, Roberson ED, Sontheimer H (2015) Vascular amyloidosis impairs the gliovascular unit in a mouse model of Alzheimer\u2019s disease. Brain 138:3716\u20133733","journal-title":"Brain"},{"key":"3897_CR32","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/BF03401867","volume":"7","author":"YM Kuo","year":"2001","unstructured":"Kuo YM, Beach TG, Sue LI, Scott S, Layne KJ, Kokjohn TA, Kalback WM, Luehrs DC et al (2001) The evolution of A beta peptide burden in the APP23 transgenic mice: implications for A beta deposition in Alzheimer disease. Mol Med 7:609\u2013618","journal-title":"Mol Med"},{"key":"3897_CR33","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/BF03401785","volume":"6","author":"YM Kuo","year":"2000","unstructured":"Kuo YM, Crawford F, Mullan M, Kokjohn TA, Emmerling MR, Weller RO, Roher AE (2000) Elevated A beta and apolipoprotein E in A betaPP transgenic mice and its relationship to amyloid accumulation in Alzheimer\u2019s disease. Mol Med 6:430\u2013439","journal-title":"Mol Med"},{"key":"3897_CR34","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1161\/ATVBAHA.120.311911","volume":"41","author":"S Scheffer","year":"2021","unstructured":"Scheffer S, Hermkens DMA, van der Weerd L, de Vries HE, Daemen M (2021) Vascular hypothesis of alzheimer disease: topical review of mouse models. Arterioscler Thromb Vasc Biol 41:1265\u20131283","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3897_CR35","doi-asserted-by":"publisher","first-page":"7130","DOI":"10.1073\/pnas.0509695103","volume":"103","author":"V Galvan","year":"2006","unstructured":"Galvan V, Gorostiza OF, Banwait S, Ataie M, Logvinova AV, Sitaraman S, Carlson E, Sagi SA et al (2006) Reversal of Alzheimer\u2019s-like pathology and behavior in human APP transgenic mice by mutation of Asp664. Proc Natl Acad Sci USA 103:7130\u20137135","journal-title":"Proc Natl Acad Sci USA"},{"key":"3897_CR36","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.1073\/pnas.96.6.3228","volume":"96","author":"AY Hsia","year":"1999","unstructured":"Hsia AY, Masliah E, McConlogue L, Yu GQ, Tatsuno G, Hu K, Kholodenko D, Malenka RC et al (1999) Plaque-independent disruption of neural circuits in Alzheimer\u2019s disease mouse models. Proc Natl Acad Sci USA 96:3228\u20133233","journal-title":"Proc Natl Acad Sci USA"},{"key":"3897_CR37","doi-asserted-by":"publisher","first-page":"4050","DOI":"10.1523\/JNEUROSCI.20-11-04050.2000","volume":"20","author":"L Mucke","year":"2000","unstructured":"Mucke L, Masliah E, Yu GQ, Mallory M, Rockenstein EM, Tatsuno G, Hu K, Kholodenko D et al (2000) High-level neuronal expression of abeta 1\u201342 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci 20:4050\u20134058","journal-title":"J Neurosci"},{"key":"3897_CR38","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/hipo.22219","volume":"24","author":"J Beauquis","year":"2014","unstructured":"Beauquis J, Vinuesa A, Pomilio C, Pavia P, Galvan V, Saravia F (2014) Neuronal and glial alterations, increased anxiety, and cognitive impairment before hippocampal amyloid deposition in PDAPP mice, model of Alzheimer\u2019s disease. Hippocampus 24:257\u2013269","journal-title":"Hippocampus"},{"key":"3897_CR39","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1038\/jcbfm.2013.82","volume":"33","author":"AL Lin","year":"2013","unstructured":"Lin AL, Zheng W, Halloran JJ, Burbank RR, Hussong SA, Hart MJ, Javors M, Shih YY et al (2013) Chronic rapamycin restores brain vascular integrity and function through NO synthase activation and improves memory in symptomatic mice modeling Alzheimer\u2019s disease. J Cereb Blood Flow Metab 33:1412\u201321","journal-title":"J Cereb Blood Flow Metab"},{"key":"3897_CR40","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.nbd.2008.11.005","volume":"33","author":"AM Simon","year":"2009","unstructured":"Simon AM, Schiapparelli L, Salazar-Colocho P, Cuadrado-Tejedor M, Escribano L, de Maturana RL, Del Rio J, Perez-Mediavilla A et al (2009) Overexpression of wild-type human APP in mice causes cognitive deficits and pathological features unrelated to Abeta levels. Neurobiol. Dis. 33:369\u201378","journal-title":"Neurobiol. Dis."},{"key":"3897_CR41","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0165-5728(97)00036-2","volume":"76","author":"MF Stins","year":"1997","unstructured":"Stins MF, Gilles F, Kim KS (1997) Selective expression of adhesion molecules on human brain microvascular endothelial cells. J Neuroimmunol 76:81\u201390","journal-title":"J Neuroimmunol"},{"key":"3897_CR42","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/2045-8118-10-33","volume":"10","author":"DE Eigenmann","year":"2013","unstructured":"Eigenmann DE, Xue G, Kim KS, Moses AV, Hamburger M, Oufir M (2013) Comparative study of four immortalized human brain capillary endothelial cell lines, hCMEC\/D3, hBMEC, TY10, and BB19, and optimization of culture conditions, for an in vitro blood-brain barrier model for drug permeability studies. Fluids Barriers CNS 10:33","journal-title":"Fluids Barriers CNS"},{"key":"3897_CR43","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3389\/fcimb.2018.00200","volume":"8","author":"MC Miraglia","year":"2018","unstructured":"Miraglia MC, Rodriguez AM, Barrionuevo P, Rodriguez J, Kim KS, Dennis VA, Delpino MV, Giambartolomei GH (2018) Brucella abortus Traverses brain microvascular endothelial cells using infected monocytes as a Trojan horse. Front Cell Infect Microbiol 8:200","journal-title":"Front Cell Infect Microbiol"},{"key":"3897_CR44","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1126\/science.161.3839.370","volume":"161","author":"P Benda","year":"1968","unstructured":"Benda P, Lightbody J, Sato G, Levine L, Sweet W (1968) Differentiated rat glial cell strain in tissue culture. Science 161:370\u2013371","journal-title":"Science"},{"key":"3897_CR45","doi-asserted-by":"publisher","first-page":"9011","DOI":"10.1021\/bi9003777","volume":"48","author":"D Ajit","year":"2009","unstructured":"Ajit D, Udan ML, Paranjape G, Nichols MR (2009) Amyloid-beta(1\u201342) fibrillar precursors are optimal for inducing tumor necrosis factor-alpha production in the THP-1 human monocytic cell line. Biochemistry 48:9011\u20139021","journal-title":"Biochemistry"},{"key":"3897_CR46","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1021\/cn2001238","volume":"3","author":"GS Paranjape","year":"2012","unstructured":"Paranjape GS, Gouwens LK, Osborn DC, Nichols MR (2012) Isolated amyloid-beta(1\u201342) protofibrils, but not isolated fibrils, are robust stimulators of microglia. ACS Chem Neurosci 3:302\u2013311","journal-title":"ACS Chem Neurosci"},{"key":"3897_CR47","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1523\/JNEUROSCI.20-02-00558.2000","volume":"20","author":"CK Combs","year":"2000","unstructured":"Combs CK, Johnson DE, Karlo JC, Cannady SB, Landreth GE (2000) Inflammatory mechanisms in Alzheimer\u2019s disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists. J Neurosci 20:558\u2013567","journal-title":"J Neurosci"},{"key":"3897_CR48","doi-asserted-by":"publisher","first-page":"104542","DOI":"10.1016\/j.nbd.2019.104542","volume":"132","author":"A Gregosa","year":"2019","unstructured":"Gregosa A, Vinuesa A, Todero MF, Pomilio C, Rossi SP, Bentivegna M, Presa J, Wenker S et al (2019) Periodic dietary restriction ameliorates amyloid pathology and cognitive impairment in PDAPP-J20 mice: potential implication of glial autophagy. Neurobiol Dis 132:104542","journal-title":"Neurobiol Dis"},{"key":"3897_CR49","doi-asserted-by":"publisher","first-page":"7753","DOI":"10.1073\/pnas.84.21.7753","volume":"84","author":"C Lagenaur","year":"1987","unstructured":"Lagenaur C, Lemmon V (1987) An L1-like molecule, the 8D9 antigen, is a potent substrate for neurite extension. Proc Natl Acad Sci U S A 84:7753\u20137757","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3897_CR50","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/hipo.22503","volume":"26","author":"C Pomilio","year":"2016","unstructured":"Pomilio C, Pavia P, Gorojod RM, Vinuesa A, Alaimo A, Galvan V, Kotler ML, Beauquis J et al (2016) Glial alterations from early to late stages in a model of Alzheimer\u2019s disease: evidence of autophagy involvement in Abeta internalization. Hippocampus 26:194\u2013210","journal-title":"Hippocampus"},{"key":"3897_CR51","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11011-021-00814-4","volume":"37","author":"R Apatiga-Perez","year":"2022","unstructured":"Apatiga-Perez R, Soto-Rojas LO, Campa-Cordoba BB, Luna-Viramontes NI, Cuevas E, Villanueva-Fierro I, Ontiveros-Torres MA, Bravo-Munoz M et al (2022) Neurovascular dysfunction and vascular amyloid accumulation as early events in Alzheimer\u2019s disease. Metab Brain Dis 37:39\u201350","journal-title":"Metab Brain Dis"},{"key":"3897_CR52","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","volume":"85","author":"A Montagne","year":"2015","unstructured":"Montagne A, Barnes SR, Sweeney MD, Halliday MR, Sagare AP, Zhao Z, Toga AW, Jacobs RE et al (2015) Blood-brain barrier breakdown in the aging human hippocampus. Neuron 85:296\u2013302","journal-title":"Neuron"},{"key":"3897_CR53","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00401-011-0834-y","volume":"122","author":"M Merlini","year":"2011","unstructured":"Merlini M, Meyer EP, Ulmann-Schuler A, Nitsch RM (2011) Vascular beta-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAbeta mice. Acta Neuropathol 122:293\u2013311","journal-title":"Acta Neuropathol"},{"key":"3897_CR54","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s11481-012-9427-3","volume":"8","author":"RS Jones","year":"2013","unstructured":"Jones RS, Minogue AM, Connor TJ, Lynch MA (2013) Amyloid-beta-induced astrocytic phagocytosis is mediated by CD36, CD47 and RAGE. J Neuroimmune Pharmacol 8:301\u2013311","journal-title":"J Neuroimmune Pharmacol"},{"key":"3897_CR55","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/jnc.12790","volume":"131","author":"A Villarreal","year":"2014","unstructured":"Villarreal A, Seoane R, Gonzalez Torres A, Rosciszewski G, Angelo MF, Rossi A, Barker PA, Ramos AJ (2014) S100B protein activates a RAGE-dependent autocrine loop in astrocytes: implications for its role in the propagation of reactive gliosis. J Neurochem 131:190\u2013205","journal-title":"J Neurochem"},{"key":"3897_CR56","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1172\/JCI58642","volume":"122","author":"R Deane","year":"2012","unstructured":"Deane R, Singh I, Sagare AP, Bell RD, Ross NT, LaRue B, Love R, Perry S et al (2012) A multimodal RAGE-specific inhibitor reduces amyloid beta-mediated brain disorder in a mouse model of Alzheimer disease. J Clin Invest 122:1377\u20131392","journal-title":"J Clin Invest"},{"key":"3897_CR57","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/jnc.15099","volume":"155","author":"JHY Yeung","year":"2020","unstructured":"Yeung JHY, Calvo-Flores Guzman B, Palpagama TH, Ethiraj J, Zhai Y, Tate WP, Peppercorn K, Waldvogel HJ et al (2020) Amyloid-beta(1\u201342) induced glutamatergic receptor and transporter expression changes in the mouse hippocampus. J Neurochem 155:62\u201380","journal-title":"J Neurochem"},{"key":"3897_CR58","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1146\/annurev-med-042915-103753","volume":"68","author":"WV Graham","year":"2017","unstructured":"Graham WV, Bonito-Oliva A, Sakmar TP (2017) Update on Alzheimer\u2019s disease therapy and prevention strategies. Annu Rev Med 68:413\u2013430","journal-title":"Annu Rev Med"},{"key":"3897_CR59","first-page":"9343514","volume":"2022","author":"SA Beshir","year":"2022","unstructured":"Beshir SA, Aadithsoorya AM, Parveen A, Goh SSL, Hussain N, Menon VB (2022) Aducanumab therapy to treat Alzheimer\u2019s disease: a narrative review. Int J Alzheimers Dis 2022:9343514","journal-title":"Int J Alzheimers Dis"},{"key":"3897_CR60","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s40265-021-01569-z","volume":"81","author":"S Dhillon","year":"2021","unstructured":"Dhillon S (2021) Aducanumab: First Approval. Drugs 81:1437\u20131443","journal-title":"Drugs"},{"key":"3897_CR61","doi-asserted-by":"publisher","first-page":"101339","DOI":"10.1016\/j.arr.2021.101339","volume":"68","author":"KI Avgerinos","year":"2021","unstructured":"Avgerinos KI, Ferrucci L, Kapogiannis D (2021) Effects of monoclonal antibodies against amyloid-beta on clinical and biomarker outcomes and adverse event risks: a systematic review and meta-analysis of phase III RCTs in Alzheimer\u2019s disease. Ageing Res Rev 68:101339","journal-title":"Ageing Res Rev"},{"key":"3897_CR62","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41582-020-00454-9","volume":"17","author":"H Fillit","year":"2021","unstructured":"Fillit H, Green A (2021) Aducanumab and the FDA - where are we now? Nat Rev Neurol 17:129\u2013130","journal-title":"Nat Rev Neurol"},{"key":"3897_CR63","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s11910-022-01235-1","volume":"22","author":"KE Foley","year":"2022","unstructured":"Foley KE, Wilcock DM (2022) Vascular considerations for amyloid immunotherapy. Curr Neurol Neurosci Rep 22:709\u2013719","journal-title":"Curr Neurol Neurosci Rep"},{"key":"3897_CR64","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1093\/brain\/awn261","volume":"131","author":"D Boche","year":"2008","unstructured":"Boche D, Zotova E, Weller RO, Love S, Neal JW, Pickering RM, Wilkinson D, Holmes C et al (2008) Consequence of Abeta immunization on the vasculature of human Alzheimer\u2019s disease brain. Brain 131:3299\u20133310","journal-title":"Brain"},{"key":"3897_CR65","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.2353\/ajpath.2009.090159","volume":"175","author":"B Liu","year":"2009","unstructured":"Liu B, Rasool S, Yang Z, Glabe CG, Schreiber SS, Ge J, Tan Z (2009) Amyloid-peptide vaccinations reduce {beta}-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer\u2019s transgenic mice. Am J Pathol 175:2099\u20132110","journal-title":"Am J Pathol"},{"key":"3897_CR66","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1002\/acn3.469","volume":"4","author":"JJ Mo","year":"2017","unstructured":"Mo JJ, Li JY, Yang Z, Liu Z, Feng JS (2017) Efficacy and safety of anti-amyloid-beta immunotherapy for Alzheimer\u2019s disease: a systematic review and network meta-analysis. Ann Clin Transl Neurol 4:931\u2013942","journal-title":"Ann Clin Transl Neurol"},{"key":"3897_CR67","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/nrneurol.2014.44","volume":"10","author":"YJ Wang","year":"2014","unstructured":"Wang YJ (2014) Alzheimer disease: lessons from immunotherapy for Alzheimer disease. Nat Rev Neurol 10:188\u2013189","journal-title":"Nat Rev Neurol"},{"key":"3897_CR68","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1111\/bpa.12895","volume":"30","author":"T Kirabali","year":"2020","unstructured":"Kirabali T, Rust R, Rigotti S, Siccoli A, Nitsch RM, Kulic L (2020) Distinct changes in all major components of the neurovascular unit across different neuropathological stages of Alzheimer\u2019s disease. Brain Pathol 30:1056\u20131070","journal-title":"Brain Pathol"},{"key":"3897_CR69","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13024-021-00512-w","volume":"17","author":"J Wang","year":"2022","unstructured":"Wang J, Fan DY, Li HY, He CY, Shen YY, Zeng GH, Chen DW, Yi X et al (2022) Dynamic changes of CSF sPDGFRbeta during ageing and AD progression and associations with CSF ATN biomarkers. Mol Neurodegener 17:9","journal-title":"Mol Neurodegener"},{"key":"3897_CR70","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/nn.4288","volume":"19","author":"MD Sweeney","year":"2016","unstructured":"Sweeney MD, Ayyadurai S, Zlokovic BV (2016) Pericytes of the neurovascular unit: key functions and signaling pathways. Nat Neurosci 19:771\u2013783","journal-title":"Nat Neurosci"},{"key":"3897_CR71","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/nn.4489","volume":"20","author":"K Kisler","year":"2017","unstructured":"Kisler K, Nelson AR, Rege SV, Ramanathan A, Wang Y, Ahuja A, Lazic D, Tsai PS et al (2017) Pericyte degeneration leads to neurovascular uncoupling and limits oxygen supply to brain. Nat Neurosci 20:406\u2013416","journal-title":"Nat Neurosci"},{"key":"3897_CR72","doi-asserted-by":"crossref","unstructured":"\u20182023 Alzheimer\u2019s disease facts and figures\u2019 (2023) Alzheimers Dement 19:1598\u2013695","DOI":"10.1002\/alz.13016"},{"key":"3897_CR73","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/nan.12375","volume":"43","author":"J Duncombe","year":"2017","unstructured":"Duncombe J, Lennen RJ, Jansen MA, Marshall I, Wardlaw JM, Horsburgh K (2017) Ageing causes prominent neurovascular dysfunction associated with loss of astrocytic contacts and gliosis. Neuropathol Appl Neurobiol 43:477\u2013491","journal-title":"Neuropathol Appl Neurobiol"},{"key":"3897_CR74","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1038\/s41467-023-37840-y","volume":"14","author":"SA Hussong","year":"2023","unstructured":"Hussong SA, Banh AQ, Van Skike CE, Dorigatti AO, Hernandez SF, Hart MJ, Ferran B, Makhlouf H et al (2023) Soluble pathogenic tau enters brain vascular endothelial cells and drives cellular senescence and brain microvascular dysfunction in a mouse model of tauopathy. Nat Commun 14:2367","journal-title":"Nat Commun"},{"key":"3897_CR75","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1750-1326-9-28","volume":"9","author":"H Li","year":"2014","unstructured":"Li H, Guo Q, Inoue T, Polito VA, Tabuchi K, Hammer RE, Pautler RG, Taffet GE et al (2014) Vascular and parenchymal amyloid pathology in an Alzheimer disease knock-in mouse model: interplay with cerebral blood flow. Mol Neurodegener 9:28","journal-title":"Mol Neurodegener"},{"key":"3897_CR76","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.4103\/1673-5374.335169","volume":"17","author":"Y Liu","year":"2022","unstructured":"Liu Y, Hu PP, Zhai S, Feng WX, Zhang R, Li Q, Marshall C, Xiao M et al (2022) Aquaporin 4 deficiency eliminates the beneficial effects of voluntary exercise in a mouse model of Alzheimer\u2019s disease. Neural Regen Res 17:2079\u20132088","journal-title":"Neural Regen Res"},{"key":"3897_CR77","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00418-014-1301-3","volume":"143","author":"RT Robertson","year":"2015","unstructured":"Robertson RT, Levine ST, Haynes SM, Gutierrez P, Baratta JL, Tan Z, Longmuir KJ (2015) Use of labeled tomato lectin for imaging vasculature structures. Histochem Cell Biol 143:225\u2013234","journal-title":"Histochem Cell Biol"},{"key":"3897_CR78","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/jnc.15096","volume":"158","author":"F Zeng","year":"2021","unstructured":"Zeng F, Liu Y, Huang W, Qing H, Kadowaki T, Kashiwazaki H, Ni J, Wu Z (2021) Receptor for advanced glycation end products up-regulation in cerebral endothelial cells mediates cerebrovascular-related amyloid beta accumulation after Porphyromonas gingivalis infection. J Neurochem 158:724\u2013736","journal-title":"J Neurochem"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03897-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-023-03897-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03897-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T06:12:31Z","timestamp":1721023951000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-023-03897-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,3]]},"references-count":78,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["3897"],"URL":"https:\/\/doi.org\/10.1007\/s12035-023-03897-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3311586\/v1","asserted-by":"object"}]},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,3]]},"assertion":[{"value":"30 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Human brain post-mortem samples were obtained from the Biobank of the Instituto de Investigaciones Neurol\u00f3gicas Dr. Ra\u00fal Carrea, FLENI (\n                      \n                      ) Buenos Aires, Argentina. FLENI\u2019s Biobank participates in the global Alzheimer\u2019s Disease Neuroimage Initiative (ADNI) and works in a collaborative and network-like manner with other brain banks in the world, only with scientific and altruistic purposes. The Biobank supplied brain specimens, anonymized antemortem information, and postmortem diagnosis. Informed consent of pre-donors authorizing the use of brain samples for research purposes was obtained by qualified personnel from the Instituto de Investigaciones Neurol\u00f3gicas Dr. Ra\u00fal Carrea and approved by the Institutional Ethics Committee (\n                      \n                      ). No separate institutional approval was required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The authors confirm consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}